Navigation Links
Cell and Gene Therapy: Taking a New Facility from Construction to Production, Upcoming Webinar Hosted by Xtalks

Join Forrest Brown, Engineering Services Manager – Northeast Region and Jarred Christofaro, Engineering Services Manager – Southeast Region of Sequence, Inc. for an informative session on Wednesday, February 26, 2020 at 1pm EST to learn about:

  • Design Flexibility: Key elements to incorporate into facility design to add manufacturing flexibility in the future, especially for CMOs
  • C&Q Strategy Development: Following a risk-based approach is key to delivering a compliant package within tight time constraints. How can you tailor the C&Q to be flexible and fit the needs of multiple clients and/or processes?
  • Scheduling Do’s and Don’ts: How to avoid project delays and how to accelerate certain phases

Cell and Gene Therapy production is one of fastest growing areas in biotechnology. There is increased demand to bring manufacturing spaces online quickly and with enough flexibility to accommodate process changes, especially for contract manufacturers. While this is becoming easier to accomplish through single-use technology and plug-and-play vendor packages, there are certainly pitfalls to navigate to ensure projects are delivered on-time and within budget.

By paying special attention to these 3 items, projects can be delivered more quickly and in a compliant fashion, greatly reducing business risk and ultimately leading to a more profitable operation. Topics of discussion will stem from both direct project experience and industry guidance from organizations such as ISPE. The use of a risk-based approach will be highlighted, as this is one of the most key elements to reducing cost and adhering to schedule. While this oftentimes means early involvement from various groups, establishing risks to the product/process early in the project lifecycle reduce costly design changes and allow for a compliant, hyper-focused C&Q plan which can meet tight schedule constraints. More attention to this at the beginning of a project ultimately saves time at the end when adherence to schedule is much more critical.

Cell and Gene Therapy projects are especially challenging. The cutting-edge nature oftentimes makes for tight timelines, but also requires a lot of flexibility considering how rapidly technology is changing. This impacts all areas of the project lifecycle, and this webinar will discuss some of the areas where key improvements can be made to save time and money.

For more information or to register for this event, visit Cell and Gene Therapy: Taking a New Facility from Construction to Production.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology technology :

1. “Stem Cell Therapy: A Rising Tide - How Stem Cells are Disrupting Medicine and Transforming Lives” - A New Book by Stem Cell Expert, Dr. Neil Riordan, Is On Sale Now
2. VetStem Biopharma CEO and Founder, Dr. Bob Harman, Interviewed in New Book "Stem Cell Therapy: A Rising Tide"
3. 5th Annual "Cancer Immunotherapy: A Long- Awaited Reality" Conference Taking Place March 26, 2015 in New York City
4. Vixiar Medical Taking up Residence at The LaunchPort™ in Port Covington
5. Taking thin films to the extreme
6. John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva
7. Spherix CEO, Anthony Hayes Appears on Bloombergs "Taking Stock With Pimm Fox"
8. Taking a new look at carbon nanotubes
9. Waterloo Heights, a Neighborhood Smiles Dental Practice is Taking a Bold New Approach to the Cavity Epidemic
10. Synagro Awarded City of Fort Worth Contract to Design-Permit-and-Construct Drum Drying Facility
11. Cirtec Medical to Open 30,000 Sq. Ft. Manufacturing Facility in Costa Rica
Post Your Comments:
(Date:3/10/2020)... ... March 10, 2020 , ... ... biopharmaceutical engineering firm, is pleased to announce the addition of Carson Dickey ... device qualification and validation in the biopharmaceutical cold chain. He provides design ...
(Date:3/3/2020)... , ... March 03, 2020 , ... ... the pharmaceutical, biotech and medical device industries, was recognized by INC. 5,000 on ... forward annual lists to note industry leaders greatly impacting their spheres of influence ...
(Date:2/26/2020)... ... February 25, 2020 , ... Continuing its ... published the results of its safety assessment on the biotechnologically produced 3-Fucolsyllactose (3-FL) ... human milk. These complex carbohydrates are indigestible and therefore function as a prebiotic ...
(Date:2/21/2020)... ... 2020 , ... Join Forrest Brown, Engineering Services Manager – Northeast Region and ... an informative session on Wednesday, February 26, 2020 at 1pm EST to ... facility design to add manufacturing flexibility in the future, especially for CMOs , ...
Breaking Biology Technology:
(Date:3/2/2020)... , ... March 02, 2020 , ... Toronto-based clinical research ... soon opening its newest office location just 5 minutes south of Clarksburg on a ... on the property, called End of the Rainbow Orchard, and decided it would be ...
(Date:2/28/2020)... , ... February 28, 2020 , ... Meridian Clinical ... 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is ... for the Best Clinical Trial Network award. These nominations were the result of two ...
(Date:2/28/2020)... ... February 27, 2020 , ... ... newest portfolio company. Established to develop and commercialize a manufacturing platform for ... Mexico State University (NMSU). The patent-pending technology results in membranes with controllable ...
Breaking Biology News(10 mins):